FDA MedWatch

FDA Safety Information and Adverse Event Reporting

Tygacil (tigecycline): Label Change - Increased Mortality Risk

Description

September 01, 2010
Healthcare professionals should consider alternatives to Tygacil in patients with severe infections.
Web Link



FDA Safety Information and Adverse Event Reporting is a sample topic found in FDA MedWatch. All other sections of this record are viewable by clicking on the index in the left column, or by clicking on "Display all Sections" in the "Content Manager".

To find other FDA MedWatch topics, please login or purchase a subscription.

Content Manager
Search Unbound MEDLINE
Display all Sections
Font Size
PrintSectionTopic